Bethesda, MD – According to filings with the U.S. Securities and Exchange Commission, Precision Medicine Group is raising $84,683,671.00 in new funding. Sources indicate as part of senior management Co-Founder, Mark Clein played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Precision Medicine Group

Formed in 2012, Precision Medicine Group is a specialized services company supporting next-generation approaches to drug development and commercialization. Precision provides an integrated infrastructure that supports pharmaceutical and life sciences companies as they develop new products in the age of precision medicine. The company is headquartered in Bethesda, Md., with offices throughout the US, Canada, and Europe.

To learn more about Precision Medicine Group, visit http://www.precisionmedicinegrp.com/

Contact:
Mark Clein, Co-Founder
240-654-0730
mark.clein@precisionmedicinegrp.com
https://www.linkedin.com/in/mark-clein-22a63a11/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved